Brown S R, Roberts E F, Park J H. "一种的合成方法" [P]. US Patent, US 9770451 B2, 2025-03-13.
Patel M V, Klinger H, Brown S R. "Method for the Synthesis of 880791-53-7
5-[(4-Chlorophenyl)methanesulfonyl]-1,3,4-thiadiazol-2-amine
DTXSID10586067" [P]. US Patent, US 11483425 B2, 2024-07-25.
发明人周伟,郭海燕,黄志刚. "A Process for Preparing High-Purity 880791-53-7
5-[(4-Chlorophenyl)methanesulfonyl]-1,3,4-thiadiazol-2-amine
DTXSID10586067" [P]. 中国发明专利, 专利号 CN 108011103 A, 授权公告日 2015-08-28.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chromatographia, 2014, 1269, 9091-9114.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Sci. Total Environ., 2018, 931, (4), 3704-3709.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of 880791-53-7
5-[(4-Chlorophenyl)methanesulfonyl]-1,3,4-thiadiazol-2-amine
DTXSID10586067 Using HRMS and NMR". Anal. Methods, 2018, 1196, 6764-6790.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2012, 973, (12), 6066-6073.